Circulating microRNAs as biomarkers, therapeutic targets, and signaling molecules

Sensors

Volumn 12, Issue 3, 2012, Pages 3359-3369

  Ajit, Seena K ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Biomarker; Exosome; MicroRNA

Indexed keywords

BIOLOGICAL MARKER; MICRORNA;

ANIMAL; EXOSOME; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; NEOPLASM; REVIEW;

ANIMALS; BIOLOGICAL MARKERS; EXOSOMES; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; NEOPLASMS;

EID: 84858973697     PISSN: 14248220     EISSN: None     Source Type: Journal    
DOI: 10.3390/s120303359     Document Type: Review

References (62)

1. Bartel, D.P. MicroRNAs: Target recognition and regulatory functions. Cell 2009, 136, 215-233.
2. Sayed, D.; Abdellatif, M. MicroRNAs in development and disease. Physiol. Rev. 2011, 91, 827-887.
3. Kaikkonen, M.U.; Lam, M.T.; Glass, C.K. Non-coding RNAs as regulators of gene expression and epigenetics. Cardiovasc. Res. 2011, 90, 430-440.
4. Chan, E.; Prado, D.E.; Weidhaas, J.B. Cancer microRNAs: From subtype profiling to predictors of response to therapy. Trends Mol. Med. 2011, 17, 235-243.
5. Dai, R.; Ahmed, S.A. MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases. Transl. Res. 2011, 157, 163-179.
6. Ceman, S.; Saugstad, J. MicroRNAs: Meta-controllers of gene expression in synaptic activity emerge as genetic and diagnostic markers of human disease. Pharmacol. Ther. 2011, 130, 26-37.
7. Jiang, Q.; Wang, Y.; Hao, Y.; Juan, L.; Teng, M.; Zhang, X.; Li, M.; Wang, G.; Liu, Y. Mir2disease: A manually curated database for microRNA deregulation in human disease. Nucleic Acids Res. 2009, 37, D98-D104.
8. Chen, X.; Ba, Y.; Ma, L.; Cai, X.; Yin, Y.; Wang, K.; Guo, J.; Zhang, Y.; Chen, J.; Guo, X.; et al. Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008, 18, 997-1006.
9. Mitchell, P.S.; Parkin, R.K.; Kroh, E.M.; Fritz, B.R.; Wyman, S.K.; Pogosova-Agadjanyan, E.L.; Peterson, A.; Noteboom, J.; O'Briant, K.C.; Allen, A.; et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. USA 2008, 105, 10513-10518.
10. Weber, J.A.; Baxter, D.H.; Zhang, S.; Huang, D.Y.; Huang, K.H.; Lee, M.J.; Galas, D.J.; Wang, K. The microRNA spectrum in 12 body fluids. Clin. Chem. 2010, 56, 1733-1741.
11. Scholer, N.; Langer, C.; Dohner, H.; Buske, C.; Kuchenbauer, F. Serum microRNAs as a novel class of biomarkers: A comprehensive review of the literature. Exp. Hematol. 2010, 38, 1126-1130.
12. Jackson, D.B. Serum-based microRNAs: Are we blinded by potential? Proc. Natl. Acad. Sci. USA 2009, 106, E5.
13. Etheridge, A.; Lee, I.; Hood, L.; Galas, D.; Wang, K. Extracellular microRNA: A new source of biomarkers. Mutat. Res. 2011, 717, 85-90.
14. de Planell-Saguer, M.; Rodicio, M.C. Analytical aspects of microRNA in diagnostics: A review. Anal. Chim. Acta 2011, 699, 134-152.
15. Meyer, S.U.; Pfaffl, M.W.; Ulbrich, S.E. Normalization strategies for microRNA profiling experiments: A 'normal' way to a hidden layer of complexity? Biotechnol. Lett. 2010, 32, 1777-1788.
16. Latham, G.J. Normalization of microRNA quantitative RT-PCR data in reduced scale experimental designs. Methods Mol. Biol. 2010, 667, 19-31.
17. Mestdagh, P.; Van Vlierberghe, P.; De Weer, A.; Muth, D.; Westermann, F.; Speleman, F.; Vandesompele, J. A novel and universal method for microRNA RT-QPCR data normalization. Genome Biol. 2009, 10, R64.
18. Sarver, A.L. Toward understanding the informatics and statistical aspects of micro-RNA profiling. J. Cardiovasc. Transl. Res. 2010, 3, 204-211.
19. Gee, H.E.; Buffa, F.M.; Camps, C.; Ramachandran, A.; Leek, R.; Taylor, M.; Patil, M.; Sheldon, H.; Betts, G.; Homer J.; et al. The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis. Br J. Cancer 2011, 104, 1168-1177.
20. Orlova, I.A.; Alexander, G.M.; Qureshi, R.A.; Sacan, A.; Graziano, A.; Barrett, J.E.; Schwartzman, R.J.; Ajit, S.K. MicroRNA modulation in complex regional pain syndrome. J. Transl. Med. 2011, 9, 195.
21. White, N.M.; Fatoohi, E.; Metias, M.; Jung, K.; Stephan, C.; Yousef, G.M. Metastamirs: A stepping stone towards improved cancer management. Nat. Rev. Clin. Oncol. 2011, 8, 75-84.
22. Reid, G.; Kirschner, M.B.; van Zandwijk, N. Circulating microRNAs: Association with disease and potential use as biomarkers. Crit. Rev. Oncol./Hematol. 2011, 80, 193-208.
23. Allen, K.E.; Weiss, G.J. Resistance may not be futile: MicroRNA biomarkers for chemoresistance and potential therapeutics. Mol. Cancer Ther. 2010, 9, 3126-3136.
24. Heneghan, H.M.; Miller, N.; Kerin, M.J. MiRNAs as biomarkers and therapeutic targets in cancer. Curr. Opin. Pharmacol. 2010, 10, 543-550.
25. Cortez, M.A.; Bueso-Ramos, C.; Ferdin, J.; Lopez-Berestein, G.; Sood, A.K.; Calin, G.A. MicroRNAs in body fluids-The mix of hormones and biomarkers. Nat. Rev. Clin. Oncol. 2011, 8, 467-477.
26. Stern-Ginossar, N.; Elefant, N.; Zimmermann, A.; Wolf, D.G.; Saleh, N.; Biton, M.; Horwitz, E.; Prokocimer, Z.; Prichard, M.; Hahn, G.; et al. Host immune system gene targeting by a viral miRNA. Science 2007, 317, 376-381.
27. Shan, J.; Feng, L.; Luo, L.; Wu, W.; Li, C.; Li, S.; Li, Y. MicroRNAs: Potential biomarker in organ transplantation. Transpl. Immunol. 2011, 24, 210-215.
28. Ladomery, M.R.; Maddocks, D.G.; Wilson, I.D. MicroRNAs: Their discovery, biogenesis, function and potential use as biomarkers in non-invasive prenatal diagnostics. Int. J. Mol. Epidemiol. Genet. 2011, 2, 253-260.
29. Ryan, P.; Atreya, C. Blood cell microRNAs: What are they and what future do they hold? Transfus. Med. Rev. 2011, 25, 247-251.
30. Landry, P.; Plante, I.; Ouellet, D.L.; Perron, M.P.; Rousseau, G.; Provost, P. Existence of a microRNA pathway in anucleate platelets. Nat. Struct. Mol. Biol. 2009, 16, 961-966.
31. Valadi, H.; Ekstrom, K.; Bossios, A.; Sjostrand, M.; Lee, J.J.; Lotvall, J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 2007, 9, 654-659.
32. Stoorvogel, W.; Kleijmeer, M.J.; Geuze, H.J.; Raposo, G. The biogenesis and functions of exosomes. Traffic 2002, 3, 321-330.
33. Raiborg, C.; Rusten, T.E.; Stenmark, H. Protein sorting into multivesicular endosomes. Curr. Opin. Cell Biol. 2003, 15, 446-455.
34. Mathivanan, S.; Simpson, R.J. Exocarta: A compendium of exosomal proteins and RNA. Proteomics 2009, 9, 4997-5000.
35. Mathivanan, S.; Fahner, C.J.; Reid, G.E.; Simpson, R.J. Exocarta 2012: Database of exosomal proteins, RNA and lipids. Nucleic Acids Res. 2012, 40, D1241-D1244.
36. Simpson, R.J.; Lim, J.W.; Moritz, R.L.; Mathivanan, S. Exosomes: Proteomic insights and diagnostic potential. Expert Rev. Proteomics 2009, 6, 267-283.
37. Record, M.; Subra, C.; Silvente-Poirot, S.; Poirot, M. Exosomes as intercellular signalosomes and pharmacological effectors. Biochem. Pharmacol. 2011, 81, 1171-1182.
38. Ramachandran, S.; Palanisamy, V. Horizontal transfer of RNAs: Exosomes as mediators of intercellular communication. Wiley Interdiscip. Rev. RNA 2011, 3, 286-293.
39. Gyorgy, B.; Szabo, T.G.; Pasztoi, M.; Pal, Z.; Misjak, P.; Aradi, B.; Laszlo, V.; Pallinger, E.; Pap, E.; Kittel, A.; et al. Membrane vesicles, current state-of-the-art: Emerging role of extracellular vesicles. Cell. Mol. Life Sci. 2011, 68, 2667-2688.
40. Turchinovich, A.; Weiz, L.; Langheinz, A.; Burwinkel, B. Characterization of extracellular circulating microRNA. Nucleic Acids Res. 2011, 39, 7223-7233.
41. Vickers, K.C.; Palmisano, B.T.; Shoucri, B.M.; Shamburek, R.D.; Remaley, A.T. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat. Cell Biol. 2011, 13, 423-433.
42. Kota, J.; Chivukula, R.R.; O'Donnell, K.A.; Wentzel, E.A.; Montgomery, C.L.; Hwang, H.W.; Chang, T.C.; Vivekanandan, P.; Torbenson, M.; Clark, K.R.; et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 2009, 137, 1005-1017.
43. Langlois, R.A.; Shapiro, J.S.; Pham, A.M.; Tenoever, B.R. In vivo delivery of cytoplasmic RNA virus-derived miRNAs. Mol. Ther. 2011, 20, 367-375.
44. Ebert, M.S.; Neilson, J.R.; Sharp, P.A. MicroRNA sponges: Competitive inhibitors of small RNAs in mammalian cells. Nat. Methods 2007, 4, 721-726.
45. Krutzfeldt, J.; Rajewsky, N.; Braich, R.; Rajeev, K.G.; Tuschl, T.; Manoharan, M.; Stoffel, M. Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005, 438, 685-689.
46. Elmen, J.; Lindow, M.; Schutz, S.; Lawrence, M.; Petri, A.; Obad, S.; Lindholm, M.; Hedtjarn, M.; Hansen, H.F.; Berger, U.; et al. Lna-mediated microRNA silencing in non-human primates. Nature 2008, 452, 896-899.
47. Shahzad, M.M.; Mangala, L.S.; Han, H.D.; Lu, C.; Bottsford-Miller, J.; Nishimura, M.; Mora, E.M.; Lee, J.W.; Stone, R.L.; Pecot, C.V.; et al. Targeted delivery of small interfering RNA using reconstituted high-density lipoprotein nanoparticles. Neoplasia 2011, 13, 309-319.
48. Pan, X.; Thompson, R.; Meng, X.; Wu, D.; Xu, L. Tumor-targeted RNA-interference: Functional non-viral nanovectors. Am. J. Cancer Res. 2011, 1, 25-42.
49. Czech, M.P.; Aouadi, M.; Tesz, G.J. RNAi-based therapeutic strategies for metabolic disease. Nat. Rev. Endocrinol. 2011, 7, 473-484.
50. Toloue, M.M.; Ford, L.P. Antibody targeted siRNA delivery. Methods Mol. Biol. 2011, 764, 123-139.
51. van Dommelen, S.M.; Vader, P.; Lakhal, S.; Kooijmans, S.A.; van Solinge, W.W.; Wood, M.J.; Schiffelers, R.M. Microvesicles and exosomes: Opportunities for cell-derived membrane vesicles in drug delivery. J. Control. Release 2011, in press.
52. Tan, A.; De La Pena, H.; Seifalian, A.M. The application of exosomes as a nanoscale cancer vaccine. Int. J. Nanomed. 2010, 5, 889-900.
53. Shim, M.S.; Kwon, Y.J. Efficient and targeted delivery of siRNA in vivo. FEBS J. 2010, 277, 4814-4827.
54. Seyhan, A.A. RNAi: A potential new class of therapeutic for human genetic disease. Hum. Genet. 2011, 130, 583-605.
55. Rivera, S.; Yuan, F. Critical issues in delivery of RNAi therapeutics in vivo. Curr. Pharm. Biotechnol. 2012, [Epub ahead of print].
56. Gilad, S.; Meiri, E.; Yogev, Y.; Benjamin, S.; Lebanony, D.; Yerushalmi, N.; Benjamin, H.; Kushnir, M.; Cholakh, H.; Melamed, N.; et al. Serum microRNAs are promising novel biomarkers. PLoS One 2008, 3, e3148.
57. Grady, W.M.; Tewari, M. The next thing in prognostic molecular markers: MicroRNA signatures of cancer. Gut 2010, 59, 706-708.
58. Wehling, M. Translational medicine: Can it really facilitate the transition of research "from bench to bedside"? Eur. J. Clin. Pharmacol. 2006, 62, 91-95.
59. Frank, R.; Hargreaves, R. Clinical biomarkers in drug discovery and development. Nat. Rev. Drug Discov. 2003, 2, 566-580.
60. Holliday, R. Epigenetics: A historical overview. Epigenetics 2006, 1, 76-80.
61. Wang, W.X.; Wilfred, B.R.; Xie, K.; Jennings, M.H.; Hu, Y.H.; Stromberg, A.J.; Nelson, P.T. Individual microRNAs (miRNAs) display distinct mRNA targeting "rules". RNA Biol. 2010, 7, 373-380.
62. Metzker, M.L. Sequencing technologies-The next generation. Nat. Rev. Genet. 2010, 11, 31-46.